J&J: Potential HIV vaccine falls short in mid-stage study – Fox News

A potential HIVvaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday.
J&J plans to end that study, which … [read more]

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.